PCN241 - OLAPARIB USE AND TREATMENT OUTCOMES IN SWEDISH PATIENTS TREATED DURING THE FIRST THREE YEARS FOLLOWING REGULATORY APPROVAL
| Autor: | Eriksson, I., Wettermark, B., Bergfeldt, K. |
|---|---|
| Zdroj: | In Value in Health October 2018 21 Supplement 3:S55-S55 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect